Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Cost-effectiveness of CDK4/6 inhibitors in HR+/HER2− metastatic breast cancer: a systematic review and meta-analysis
PaperCitations, authors & open-access status
Cost-effectiveness of CDK4/6 inhibitors in HR+/HER2− metastatic breast cancer: a systematic review and meta-analysis is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 11 citations, 2024 year and closed oa status.
11
Citations
2024
Year
closed
OA Status